semaglutide weight loss with ongoing nurse support Another Weight-Loss Trial Win for Weekly GLP-1 Drug Ending the week with this

Propensity scorematched cohorts were built to compare (1) 4606 patients who received GLP-1 receptor agonistSGLT-2 inhibitor combination with 18,424 who received only GLP-1 receptor agonist, and (2) 5368 patients who received this combination with 21,472 who received only SGLT-2 inhibitors

Research from the STEP trials (semaglutide) and SURMOUNT trials (tirzepatide) demonstrates that GLP-1 agonists produce 1522% body weight loss in people with obesity, significantly outperforming older weight loss medications

To confirm this result, a cystatin C-based eGFR was used to show a similar significant difference in the loss of kidney function favoring semaglutide

Semaglutide is also making changes in peoples lives as well to help lose stubborn weight

Take biotin with your first meal of the day during your eating window for optimal absorption and to support metabolic processes throughout the day